Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia

Authors: Shaharudin Rafiza, Krishna Gopal Rampal, Aris Tahir

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Health care workers are exposed to patients with tuberculosis and are at risk of nosocomial infection. The aim of this study was to determine the prevalence and factors associated with latent tuberculosis infection among health care workers in Malaysia and also to evaluate the agreement between Quantiferon TB Gold in tube test with Tuberculin Skin Test.

Methods

A cross sectional study was conducted at four randomly selected hospitals in the Klang Valley from December 2008 to May 2009. Self administered questionnaire was used to obtain information on health care workers and possible risk factors. The response rate for this study was 90.8% with 954 respondents completed the questionnaire and were tested with Quantiferon TB Gold in tube for latent tuberculosis infection. Agreement between Quantiferon TB Gold in tube and Tuberculin Skin Test was assessed among 95 health care workers who consented to undergo both tests.

Results

The overall prevalence of latent tuberculosis infection among health care workers was 10.6% (CI: 8.6%; 12.6%). Factors significantly associated with latent tuberculosis infection were aged 35 years and older [9.49 (CI: 2.22; 40.50)], history of living in the same house with close family members or friends who had active tuberculosis [8.69 (CI: 3.00; 25.18)], worked as a nurse [4.65 (CI: 1.10; 19.65)] and being male [3.70 (CI: 1.36; 10.02)]. Agreement between Quantiferon TB Gold in tube test and tuberculin skin test at cut-off points of 10 mm and 15 mm was 50.5% and 82.1% respectively. However, Kappa-agreement was poor for both cut-off points.

Conclusion

The prevalence of latent tuberculosis infection in Malaysia was relatively low for an intermediate TB burden country. We could not comment on the occupational risk of latent tuberculosis infection among health care worker compared to the general population as there were no prevalence data available for latent tuberculosis infection in the general population. Kappa agreement between Quantiferon TB gold in-tube and tuberculin skin test was poor.
Appendix
Available only for authorised users
Literature
1.
go back to reference Glaziou P, Floyd K, Raviglione M: Global burden and epidemiology of tuberculosis. Clin Chest Med. 2009, 30 (4): 621-36. 10.1016/j.ccm.2009.08.017.CrossRefPubMed Glaziou P, Floyd K, Raviglione M: Global burden and epidemiology of tuberculosis. Clin Chest Med. 2009, 30 (4): 621-36. 10.1016/j.ccm.2009.08.017.CrossRefPubMed
2.
go back to reference Ministry of Health (MOH): National tuberculosis control programme, Disease Control Division. 2008 Ministry of Health (MOH): National tuberculosis control programme, Disease Control Division. 2008
3.
go back to reference Brennan PJ: Tuberculosis in the context of emerging and reemerging diseases. FEMS Immunology & Medical Microbiology. 1997, 18: 263-269.CrossRef Brennan PJ: Tuberculosis in the context of emerging and reemerging diseases. FEMS Immunology & Medical Microbiology. 1997, 18: 263-269.CrossRef
4.
go back to reference Andersen P, Munk ME, Pollock JM, Doherty TM: Specific immune-based diagnosis of tuberculosis. Lancet. 2000, 356 (9235): 1099-1104. 10.1016/S0140-6736(00)02742-2.CrossRefPubMed Andersen P, Munk ME, Pollock JM, Doherty TM: Specific immune-based diagnosis of tuberculosis. Lancet. 2000, 356 (9235): 1099-1104. 10.1016/S0140-6736(00)02742-2.CrossRefPubMed
5.
go back to reference Menzies D, Pai M, Comstock G: Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 2007, 146: 340-54.CrossRefPubMed Menzies D, Pai M, Comstock G: Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 2007, 146: 340-54.CrossRefPubMed
6.
go back to reference Kang YA, Lee HW, Yoon HI, Cho BL, Han SK, Shim YS, Yim JJ: Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA. 2005, 293 (22): 2756-61. 10.1001/jama.293.22.2756.CrossRefPubMed Kang YA, Lee HW, Yoon HI, Cho BL, Han SK, Shim YS, Yim JJ: Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA. 2005, 293 (22): 2756-61. 10.1001/jama.293.22.2756.CrossRefPubMed
7.
go back to reference Joshi R, Reingold AL, Menzies D, Pai M: Tuberculosis among health-care workers in low and middle income countries: a systematic review. PLoS Med. 2006, 3 (12): 2376-91. 10.1371/journal.pmed.0030494.CrossRef Joshi R, Reingold AL, Menzies D, Pai M: Tuberculosis among health-care workers in low and middle income countries: a systematic review. PLoS Med. 2006, 3 (12): 2376-91. 10.1371/journal.pmed.0030494.CrossRef
8.
go back to reference Schablon A, Harling M, Diel R, Nienhaus A: Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study. BMC Infectious Diseases. 2010, 10 (107): Schablon A, Harling M, Diel R, Nienhaus A: Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study. BMC Infectious Diseases. 2010, 10 (107):
9.
go back to reference Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T: Screening for Tuberculosis Infection Using Whole-Blood Interferon- gamma and Mantoux Testing Among Japanese Healthcare Workers. Infect Control Hosp Epidemiol. 2006, 27 (5): 442-8. 10.1086/504358.CrossRefPubMed Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T: Screening for Tuberculosis Infection Using Whole-Blood Interferon- gamma and Mantoux Testing Among Japanese Healthcare Workers. Infect Control Hosp Epidemiol. 2006, 27 (5): 442-8. 10.1086/504358.CrossRefPubMed
10.
go back to reference Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM: Mycobacterium tuberculosis infection in health care workers in rural India. JAMA. 2005, 293 (22): 2746-55. 10.1001/jama.293.22.2746.CrossRefPubMed Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM: Mycobacterium tuberculosis infection in health care workers in rural India. JAMA. 2005, 293 (22): 2746-55. 10.1001/jama.293.22.2746.CrossRefPubMed
11.
go back to reference CDC: Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings. MMWR. 2005, 54 (RR17): 1-140. CDC: Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings. MMWR. 2005, 54 (RR17): 1-140.
12.
go back to reference Franchi A, Richeldi L, Parrinello G, Franco G: Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient. Int Arc Occup Environ Health. 2007, 80: 533-8. 10.1007/s00420-006-0160-1.CrossRef Franchi A, Richeldi L, Parrinello G, Franco G: Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient. Int Arc Occup Environ Health. 2007, 80: 533-8. 10.1007/s00420-006-0160-1.CrossRef
13.
go back to reference Haley CA, Cain KP, Yu C, Garman KF, Wells CD, Laserson KF: Risk-based screening for latent tuberculosis infection. Southern Med J. 2008, 101 (2): 142-9.CrossRefPubMed Haley CA, Cain KP, Yu C, Garman KF, Wells CD, Laserson KF: Risk-based screening for latent tuberculosis infection. Southern Med J. 2008, 101 (2): 142-9.CrossRefPubMed
14.
go back to reference Koppaka VR, Harvey E, Mertz B, Johnson BA: Risk factors associated with tuberculin skin test positivity among university students and the use of such factors in the development of a targeted screening program. Clin Infect Dis. 2003, 36: 599-607.. 10.1086/367664.CrossRefPubMed Koppaka VR, Harvey E, Mertz B, Johnson BA: Risk factors associated with tuberculin skin test positivity among university students and the use of such factors in the development of a targeted screening program. Clin Infect Dis. 2003, 36: 599-607.. 10.1086/367664.CrossRefPubMed
15.
go back to reference Nienhaus A, Schablon A, Diel R: Interferon-gamma release assay for the diagnosis of latent TB infection - Analysis of discordant results, when compared to the tuberculin skin test. PLoS Med. 2008, 3 (7): e2665-CrossRef Nienhaus A, Schablon A, Diel R: Interferon-gamma release assay for the diagnosis of latent TB infection - Analysis of discordant results, when compared to the tuberculin skin test. PLoS Med. 2008, 3 (7): e2665-CrossRef
Metadata
Title
Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia
Authors
Shaharudin Rafiza
Krishna Gopal Rampal
Aris Tahir
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-19

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine